CLINICAL TRIALS PROFILE FOR TESTIM
✉ Email this page to a colleague
All Clinical Trials for TESTIM
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00156650 ↗ | Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 1/Phase 2 | 2004-12-01 | This study is being offered to all participants of the ACY-5 study as an optional addition to the male contraceptive study in which they participated. Participation is voluntary. The purpose of this added procedure (Testicular Aspiration-HOP 3) is to determine the amount of testosterone (male hormone) in the testes of men who are on a male contraceptive regimen. |
NCT00156650 ↗ | Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum | Completed | University of Washington | Phase 1/Phase 2 | 2004-12-01 | This study is being offered to all participants of the ACY-5 study as an optional addition to the male contraceptive study in which they participated. Participation is voluntary. The purpose of this added procedure (Testicular Aspiration-HOP 3) is to determine the amount of testosterone (male hormone) in the testes of men who are on a male contraceptive regimen. |
NCT00161447 ↗ | Male Hormonal Contraceptive Development-ACY-5 | Completed | CONRAD | Phase 1/Phase 2 | 2004-05-01 | The purpose of this research study is to help in the development of male contraception (birth control). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TESTIM
Condition Name
Clinical Trial Locations for TESTIM
Trials by Country
Clinical Trial Progress for TESTIM
Clinical Trial Phase
Clinical Trial Sponsors for TESTIM
Sponsor Name